EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neuropathology of α‐synuclein in Parkinson's disease

Chi-Jing Choong, Hideki Mochizuki iD

Neuropathology · 2022-04 · 42 (2) · 93-103

DOI: 10.1111/neup.12812 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuropathology, online erschienen am 31.03.2022. Verfasst von Chi-Jing Choong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive movement disability accompanied by non‐motor symptoms. The neuropathology hallmark of PD is the loss of dopaminergic neurons predominantly in the substantia nigra pars compacta and the presence of intracellular inclusions termed Lewy bodies (LBs), which are mainly composed of α‐synuclein (αSyn). Detailed staging based on the distribution and progression pattern of αSyn pathology in the postmortem brains of PD patients revealed correlation with the clinical phenotypes but not invariably. Cumulative evidence from cell and animal studies has implied that αSyn propagation contributes to the anatomical spread of αSyn pathology in the brain. Here, we recount the studies over the past two centuries on the anatomopathological foundations of PD documented. We also review studies on the structural analysis of αSyn and LBs, Braak staging of αSyn pathology, the cell‐to‐cell propagation of αSyn as well as αSyn fibril polymorphisms, which underlie the phenotypic differences in synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson Diseasealpha-SynucleinAnimalsDopaminergic NeuronsHumansLewy BodiesNeuropathology

Stichwörter der Autor:innen

Parkinson's diseasedopaminergic neuronfibril polymorphismsubstantia nigraα-synuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.

ORCID-Profile: Hideki Mochizuki

Förderung

  • Japan Agency for Medical Research and Development
  • AMED

Zitieren

APA

Choong, C. J., & Mochizuki, H. (2022). Neuropathology of α‐synuclein in Parkinson's disease. Neuropathology, 42(2), 93-103. https://doi.org/10.1111/neup.12812

Vancouver

Choong CJ, Mochizuki H. Neuropathology of α‐synuclein in Parkinson's disease. Neuropathology. 2022;42(2):93-103. doi:10.1111/neup.12812

BibTeX
@article{Choong2022,
  author = {Choong, Chi-Jing and Mochizuki, Hideki},
  title = {Neuropathology of α‐synuclein in Parkinson's disease},
  journal = {Neuropathology},
  year = {2022},
  volume = {42},
  number = {2},
  pages = {93--103},
  doi = {10.1111/neup.12812}
}
Kostenlos starten →